June 8, 2005
Re "Drug CEO's Business Becomes Personal," June 1: I read the article with my heart pounding, tears welling, eager to get to the end to see if, in fact, a viable treatment or cure has been found for multiple myeloma. My husband, Steve, had the exact journey as Richard Brewer -- same symptoms, same doctor at City of Hope, same stem cell treatment -- but his remission lasted only two years. He died in December 2003, five years after diagnosis. Kudos to Brewer and researcher Linda Higgins and her team for their perseverance and to Johnson & Johnson for picking up the ball.
October 21, 2002 |
Most doctors used to think that the way to cure cancer was to attack it with every conceivable weapon. Now some are trying, instead, to disrupt the disease's environment. In a clinical trial completed earlier this year, a drug based on this approach helped prolong the lives of a majority of people with late-stage multiple myeloma, a deadly cancer that destroys bone tissue. The drug, Velcade, is known as a proteasome inhibitor.
July 21, 2002 |
I fielded the phone call impatiently. Another earnest PR agent, trying to interest me in her client's concern. This one wanted me to write about cancer, the kind of cancer that killed Ann Landers, an under-the-radar variety that too few people know about, and too many people fear. I cut her off. Too busy, I told her. No one wants to read a column on disease. But she stopped me cold when she said the name: Multiple myeloma. That's the cancer that killed my mom.
CALIFORNIA | LOCAL
July 4, 2000
Harold Crockett Pillsbury Jr., 77, a chemist who tested cigarettes for the Federal Trade Commission. Pillsbury directed the FTC's cigarette-testing laboratory from its inception after a landmark 1964 study by the surgeon general, which linked smoking to health problems, until it was closed by funding cuts in 1987. Pillsbury retired as an FTC chemist in 1989 after 25 years with the department.
May 29, 2000 |
Health spoke to Dr. Brian Durie, chairman of the board of the International Myeloma Foundation and director of the Myeloma Clinic at Cedars-Sinai Comprehensive Cancer Center. Question: Myeloma has been in the news a lot lately, especially in the sports world.
August 16, 1999
The International Myeloma Foundation will hold an all-day seminar for patients and their families on Saturday at the Universal City Hilton and Towers. Multiple myeloma is a little-known, fatal cancer of the bone marrow that affects from 75,000 to 100,000 people in the U.S. With more than 13,500 new cases diagnosed each year, it is one of the fastest-growing types of cancer in the Western hemisphere.